Lupin Launches First Generic of Pred Forte(r) in US
Looking Into AbbVie's Recent Short Interest
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
AbbVie's Q3 2024 Earnings: What to Expect
AbbVie To Go Ex-Dividend On October 15th, 2024 With 1.55 USD Dividend Per Share
October 13th (Eastern Time) - $AbbVie(ABBV.US)$ is trading ex-dividend on October 15th, 2024.Shareholders of record on October 15th, 2024 will receive 1.55 USD dividend per share on November 15th, 202
Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $218
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Ionis Pharmaceuticals (IONS) and Amicus (FOLD)
Dividend Roundup: Pfizer, Caterpillar, PNC Financial, AbbVie, and More
AbbVie (ABBV) Stock Moves -0.21%: What You Should Know
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Possible Bearish Signals With AbbVie Insiders Disposing Stock
Truist Financial Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $215
Express News | Abbvie : Truist Securities Raises Target Price to $215 From $210
Express News | Ebrd, Ifc to Provide $435 Mln to Ukraine's Newly Merged Telecoms Company, Lenders Say
AbbVie Snaps Six Days of Losses, Trades in the Green
Will AbbVie (ABBV) Beat Estimates Again in Its Next Earnings Report?
AbbVie's Options: A Look at What the Big Money Is Thinking
UBS Downgrades AbbVie(ABBV.US) to Hold Rating, Raises Target Price to $195
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It